Start Date
Not specified
HBOC-201
Intravenous administration of a hemoglobin based oxygen carrier (HBOC) in patients with life-threatening anemia, for whom allogeneic blood transfusion is not an option.
The Johns Hopkins Hospital, Baltimore
Collaborators (1)
HbO2 Therapeutics LLC
INDUSTRY
Johns Hopkins University
OTHER